Under Pressure: Recent Episodes
...
A brief, recurring podcast for busy clinicians and investigators devoted to state-of-the-art prevention and control of blood pressure. We provide quick, lively, and accurate updates and reviews on important issues in hypertension.
Listen in as we learn from our guest speaker, Dr. Yvonne Commodore-Mensah, about her "glocal" work exploring healthy equity issues in hypertension prevention and management for people of African descent both in Ghana and in the United States.
Join us as we learn from our guest speaker, Dr. Anika Hines, about her fascinating research on structural racism, interpersonal racism and social determinants of health. In particular, we will explore how these things impact cardiovascular health and hear about her work on ways we can holistically address stress, improve health and empower patients.
Listen in for a review of the ACCORD BP trial, another episode in our series of podcasts devoted to discussing the landmark trials that have informed care and guidelines for the care of patients with hypertension. The ACCORD (Action to Control Cardiovascular Risk in Diabetes) BP trial explored whether intensive BP control (<120 mmHg) reduced rates of nonfatal MI, nonfatal stroke or CV mortality when compared with standard (<140 mmHg) blood pressure targets. Spoiler alert: it's complicated!!
Join us as we welcome Dr. Jordana Cohen, a nephrologist and a hypertension specialist at UPenn for a discussion about why (and how!) we should be looking for more primary aldosteronism in our patients with hypertension.
Listen in for a review and discussion of HYVET (HYpertension in the Very Elderly Trial), a landmark trial in the field of hypertension research that began the fundamental shift in how we consider blood pressure thresholds for our older patients.
Join us and learn from Anthony Ishak, our clinical pharmacist, who provides an overview of the nuances of different ARBs and ACE inhibitors in hypertension treatment.
Many may not be aware that medications, both prescription and over the counter, can RAISE your blood pressure. Join us to learn from special guest, Tim Anderson, as he describes his recent publication in JAMA IM that details which medications may be the culprits and how often patients with hypertension are taking them.
We welcome a special invited guest, Dr. Phillip Levy of Wayne State University, to describe how he and his team turned mobile health units into a valuable tool to address hypertension in vulnerable communities in Detroit, Michigan during the covid pandemic.
Join us as we hear from expert Dr. Ruth-Alma Turkson-Ocran about the disparities in cardiovascular care between white and non-white patients, define social determinants of health and learn about the importance of shared decision making in our clinical practices.
In our first segment we discuss home blood pressure monitors, including how to chose them and how to use them. For our second segment, we review the SSaSS trial which evaluated the impact of using a salt substitute instead of salt among patients with prior stroke.
During our literature review segment, another one of our stellar primary care track residents reviews the findings of the ALLHAT trial. Then, we are joined by our clinical pharmacist who gives an overview of the major thiazide diuretics we use for hypertension treatment (chlorthalidone, indapamide and hydrochlorothiazide).
For our clinical case, we discuss the clinical course and treatment options for postpartum hypertension as well as the long term cardiovascular risk implications for women who have this. During our literature review segment, one of our stellar primary care track residents takes us through important aspects of the landmark 2015 SPRINT trial.
For our clinical case, we discuss the impact that antihypertensive medications can have on Raynaud’s phenomenon. We then explore the impact of sodium reduction on blood pressure control and cardiovascular outcomes by reviewing a meta-analysis of 85 clinical trials.